triazoles has been researched along with Leishmaniasis in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 14 (73.68) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Boechat, N; Castelo-Branco, FS; França, RRF; Hoelz, LVB; Menozzi, CAC | 1 |
| Aucamp, J; N'Da, DD; Viljoen, M; Zuma, NH | 1 |
| Andreazza Costa, MC; Borsodi, MPG; Cabral Abreu Grijó, B; Castro Ferreira, MM; Costa, AV; Lima, WP; Rodrigues Gazolla, PA; Rossi Bergmann, B; Teixeira, RR | 1 |
| Becker, DP; Caulfield, TR; Durvasula, R; Goicoechea, S; Gupta, Y; Kempaiah, P; Mathur, R; Romero, JG | 1 |
| Braga, SS | 1 |
| Abid, M; Ahmad, MB; Azam, A; Daniliuc, CG; Hasan, P; Masood, MM; Rub, A; Sonawane, YA; Tabrez, S; Yadava, U | 1 |
| Caballero, AB; Esteban-Parra, GM; Méndez-Arriaga, JM; Salas, JM | 1 |
| Carvalho, I; Chierrito, TPC; de Andrade, P; Figueredo, AS; Mantoani, SP | 1 |
| Barbosa, LCA; Csuk, R; de Almeida, RM; Demuner, AJ; Ferreira, SR; Fujiwara, RT; Heller, L; Nain-Perez, A; Rodríguez-Hernández, D | 1 |
| Cardona-G, W; Herrera-R, A; Yepes, AF | 1 |
| Caballero, AB; Gutiérrez-Sánchez, R; Marín, C; Ramírez-Macías, I; Rodríguez-Diéguez, A; Salas, JM; Sánchez-Moreno, M; Santamaría-Díaz, N | 1 |
| Abarca, B; Adam, R; Alzuet-Piña, G; Ballesteros, R; Bilbao-Ramos, P; Dea-Ayuela, MA; González-Rosende, ME; López-Molina, S | 1 |
| Caballero, AB; Chaves-Lemaur, G; Gutierrez-Sánchez, R; Huertas, Ó; Marín, C; Olmo, F; Quirós, M; Ramírez-Macías, I; Rodríguez-Diéguez, A; Salas, JM; Sánchez-Moreno, M | 1 |
| Ballard, J; Barnes, SW; Biggart, A; Brock, A; Buckner, FS; Bursulaya, B; Davis, LC; Federe, G; Gao, MY; Gillespie, JR; Glynne, RJ; Groessl, T; Khare, S; Koh, HX; Lai, YH; Liang, F; Liu, X; Mathison, CJ; Mishra, PK; Molteni, V; Mottram, JC; Myburgh, E; Nagle, AS; Rao, SP; Rivera, IC; Shapiro, M; Spraggon, G; Stinson, M; Supek, F; Tan, JL; Tuntland, T; Venable, JD; Walker, JR; Wen, BG; Yeh, V | 1 |
| Benicewicz, DB; Chen, PC; Gryder, B; Guerrant, W; Khan, SI; Oyelere, AK; Patil, V; Tekwani, BL | 1 |
| Ardestani, SK; Dastmalchi, S; Emami, S; Foroumadi, A; Foroumadi, P; Kobarfard, F; Mahdavi, M; Razmi, S; Shafiee, A; Tahghighi, A | 1 |
| Benaim, B; Garcia, CR | 1 |
| Barrett, MP; Croft, SL | 1 |
| Abdala-Valencia, H; Le Baut, G; Le Borgne, M; Le Pape, P; Marchand, P; Pagniez, F; Robert-Piessard, S | 1 |
7 review(s) available for triazoles and Leishmaniasis
| Article | Year |
|---|---|
The Medicinal Chemistry of 3-nitro-1,2,4-triazoles: Focus on Infectious Diseases.
Topics: Animals; Chagas Disease; Chemistry, Pharmaceutical; Communicable Diseases; Humans; Leishmaniasis; Mycoses; Triazoles; Trypanosomiasis, African; Tuberculosis | 2021 |
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Leishmanicidal and Trypanocidal Activity of Metal Complexes with 1,2,4-Triazolo[1,5-a]pyrimidines: Insights on their Therapeutic Potential against Leishmaniasis and Chagas Disease.
Topics: Animals; Antiprotozoal Agents; Chagas Disease; Coordination Complexes; Humans; Leishmania; Leishmaniasis; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Trypanosoma | 2017 |
Potential Triazole-based Molecules for the Treatment of Neglected Diseases.
Topics: Animals; Antiprotozoal Agents; Chagas Disease; Humans; Leishmaniasis; Malaria; Triazoles; Tuberculosis | 2019 |
Hybrid Molecules: Promising Compounds for the Development of New Treatments Against Leishmaniasis and Chagas Disease.
Topics: Antiprotozoal Agents; Chagas Disease; Chalcone; Humans; Hydrazones; Leishmaniasis; Pentamidine; Quinolines; Terpenes; Triazoles | 2018 |
Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
Topics: Amiodarone; Antiprotozoal Agents; Calcium; Chagas Disease; Homeostasis; Humans; Leishmania; Leishmaniasis; Phosphorylcholine; Triazoles; Trypanosoma brucei brucei; Trypanosoma cruzi | 2011 |
Management of trypanosomiasis and leishmaniasis.
Topics: Administration, Oral; Africa; Amphotericin B; Antiprotozoal Agents; Benzamides; Boron Compounds; Chagas Disease; Drug Therapy, Combination; Humans; India; Leishmaniasis; Nitroimidazoles; Pentamidine; Triazoles; Trypanosomiasis, African | 2012 |
12 other study(ies) available for triazoles and Leishmaniasis
| Article | Year |
|---|---|
Synthesis, in vitro Antileishmanial Efficacy and Hit/Lead Identification of Nitrofurantoin-Triazole Hybrids.
Topics: Antiprotozoal Agents; Humans; Leishmaniasis; Nitrofurantoin; Prospective Studies; Triazoles | 2022 |
Eugenol derivatives with 1,2,3-triazole moieties: Oral treatment of cutaneous leishmaniasis and a quantitative structure-activity relationship model for their leishmanicidal activity.
Topics: Animals; Antiprotozoal Agents; Eugenol; Female; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine Antimoniate; Mice; Quantitative Structure-Activity Relationship; Structure-Activity Relationship; Triazoles | 2022 |
Repurposing Lansoprazole and Posaconazole to treat leishmaniasis: Integration of in vitro testing, pharmacological corroboration, and mechanisms of action.
Topics: Antiprotozoal Agents; Drug Repositioning; Humans; In Vitro Techniques; Lansoprazole; Leishmania; Leishmaniasis; Triazoles | 2022 |
Anti-leishmanial and cytotoxic activities of amino acid-triazole hybrids: Synthesis, biological evaluation, molecular docking and in silico physico-chemical properties.
Topics: Amino Acids; Antiprotozoal Agents; Click Chemistry; Humans; Leishmania donovani; Leishmaniasis; Molecular Docking Simulation; NADH, NADPH Oxidoreductases; Triazoles | 2017 |
Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
Topics: Animals; Antiprotozoal Agents; Carbon-13 Magnetic Resonance Spectroscopy; Cells, Cultured; Dogs; Hep G2 Cells; Humans; Leishmaniasis; Oleanolic Acid; Proton Magnetic Resonance Spectroscopy; Triazoles | 2017 |
Lanthanide complexes containing 5-methyl-1,2,4-triazolo[1,5-a] pyrimidin-7(4H)-one and their therapeutic potential to fight leishmaniasis and Chagas disease.
Topics: Animals; Antiprotozoal Agents; Chagas Disease; Chlorocebus aethiops; Coordination Complexes; Crystallography, X-Ray; Female; Inhibitory Concentration 50; Lanthanoid Series Elements; Leishmania; Leishmania braziliensis; Leishmania infantum; Leishmaniasis; Ligands; Pyrimidinones; Rats; Triazoles; Trypanosoma cruzi; Vero Cells | 2014 |
Triazolopyridyl ketones as a novel class of antileishmanial agents. DNA binding and BSA interaction.
Topics: Animals; Antiprotozoal Agents; Binding, Competitive; Cattle; Cell Line; Cell Survival; Disease Models, Animal; DNA; Ketones; Leishmania; Leishmaniasis; Liver; Mice; Protein Binding; Pyridines; Serum Albumin, Bovine; Spectrometry, Fluorescence; Spleen; Triazoles | 2014 |
Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis.
Topics: Animals; Chagas Disease; Chlorocebus aethiops; Extracellular Space; Female; Inhibitory Concentration 50; Intracellular Space; Leishmania braziliensis; Leishmania infantum; Leishmaniasis; Mice; Models, Molecular; Molecular Conformation; Organometallic Compounds; Transition Elements; Triazoles; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells | 2014 |
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness.
Topics: Animals; Chagas Disease; Chymotrypsin; Disease Models, Animal; Female; Humans; Inhibitory Concentration 50; Kinetoplastida; Leishmaniasis; Mice; Molecular Structure; Molecular Targeted Therapy; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrimidines; Species Specificity; Triazoles; Trypanosomiasis, African | 2016 |
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group.
Topics: Antimalarials; Antiprotozoal Agents; Histone Deacetylase Inhibitors; Histone Deacetylases; Leishmania donovani; Leishmaniasis; Malaria; Plasmodium falciparum; Structure-Activity Relationship; Triazoles | 2010 |
Synthesis and anti-leishmanial activity of 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-amines containing N-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl] moieties.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Leishmania major; Leishmaniasis; Macrophages, Peritoneal; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiadiazoles; Triazoles | 2012 |
Antileishmanial activities and mechanisms of action of indole-based azoles.
Topics: Animals; Antiprotozoal Agents; Azoles; Disease Models, Animal; Dose-Response Relationship, Drug; Ergosterol; Imidazoles; Indoles; Interleukin-4; Leishmania major; Leishmania mexicana; Leishmaniasis; Liver; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Molecular Structure; Parasitic Sensitivity Tests; Phospholipases A; Sensitivity and Specificity; Spleen; Triazoles | 2006 |